Publications by authors named "Noel R Monks"

17Publications

Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy.

Mol Ther 2017 08 2;25(8):1917-1932. Epub 2017 Jun 2.

MedImmune, LLC, One Medimmune Way, Gaithersburg, MD 20878, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2017.05.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542805PMC
August 2017

Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemia.

Pediatr Blood Cancer 2017 Nov 27;64(11). Epub 2017 Apr 27.

Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501879PMC
November 2017

Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms.

Am J Cancer Res 2015 15;5(4):1507-18. Epub 2015 Mar 15.

Center for Translational Medicine, Van Andel Research Institute Grand Rapids, Michigan, USA ; Current address: Medimmune, One MedImmune Way Gaithersburg, MD, 20878, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473327PMC
June 2015

Melanoma genotypes and phenotypes get personal.

Lab Invest 2013 Aug 1;93(8):858-67. Epub 2013 Jul 1.

Division of Surgical Oncology, Lacks Cancer Center at Mercy Health-Saint Mary's, CHE/Trinity Health, Inc, Grand Rapids, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.2013.84DOI Listing
August 2013

Addressing the design of in vitro models for the investigation of microcystins: the essential role of transporter-mediated uptake.

Cell Biol Int 2010 Sep;34(9):907-9

Van Andel Research Institute, Grand Rapids, MI 49503, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/CBI20100244DOI Listing
September 2010

Abrogation of microcystin cytotoxicity by MAP kinase inhibitors and N-acetyl cysteine is confounded by OATPIB1 uptake activity inhibition.

Toxicon 2010 Apr 24;55(4):827-37. Epub 2009 Nov 24.

Department of Pediatrics, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.toxicon.2009.11.019DOI Listing
April 2010

Sensitivity of breast cancer cell lines to recombinant thiaminase I.

Cancer Chemother Pharmacol 2010 May 15;66(1):171-9. Epub 2009 Oct 15.

Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Kentucky College of Medicine, 740 S Limestone Room J457, Lexington, KY 40536, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1148-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040657PMC
May 2010

Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells.

Mol Cancer Ther 2007 Feb;6(2):587-98

Department of Pediatrics, University of Kentucky, Room J457, 740 S. Limestone, Lexington, KY 40502, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-06-0500DOI Listing
February 2007

Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.

J Cell Biochem 2006 May;98(1):221-33

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.20789DOI Listing
May 2006